Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

10 Jul 2013 14:40

RNS Number : 0370J
Maven Income & Growth VCT PLC
10 July 2013
 



Maven Income and Growth VCT PLC (the Company)

 

Interim Management Statement - Quarter Ended 31 May 2013

 

This Interim Management Statement, for the quarter ended 31 May 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 June 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

·; Net asset value (NAV)1 of 70.9p per share at 31 May 2013, compared to 70.6p per share at 28 February 2013;

·; NAV total return2 of 120.5p at 31 May 2013, compared to 120.2p at 28 February 2013; and

·; Final dividend of 3.5p per share in respect of the year ending 28 February 2013 to be paid on 19 July 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 May 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 28 February 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 31 May 2013, a total of £106,258 was invested in support of three existing portfolio companies and an aggregate £2,294,429 was invested in two new unlisted investments. During the same period, net proceeds of £2,001,634 were realised from UK government securities; the sale of an AIM quoted holding realised proceeds of £12,283 against cost of £8,233; and the full or partial disposal of five unlisted holdings realised total proceeds of £2,914,300 against an aggregate cost of £1,176,191.

 

3.

Recent developments

 

Between 1 June 2013 and the date of this Statement, the Company provided an additional aggregate investment of £321,540 in support of two existing portfolio companies and made a total net investment of £3,433,352 in five new private companies. During the same period, £1,500,000 of proceeds were realised from UK government securities; and the partial disposal of three unlisted or AIM quoted holdings realised proceeds of £221,316 against an invested cost of £290,330.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 March 2013 to 31 May 2013, or in the period from 1 June 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

10 July 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGURWMUPWGWU
Date   Source Headline
6th Apr 202112:50 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSIssue of Equity
24th Mar 20215:56 pmRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
8th Feb 20219:56 amRNSStatement re Offer for Subscription
4th Feb 20215:10 pmRNSTransaction in Own Shares
29th Jan 20214:42 pmRNSTransaction in Own Shares
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
22nd Jan 20213:13 pmRNSNet Asset Value(s)
27th Nov 202010:41 amRNSResult of General Meeting
20th Nov 20205:18 pmRNSIssue of Equity
16th Nov 20204:53 pmRNSTransaction in Own Shares
13th Nov 20203:43 pmRNSStatement re Dividend Investment Scheme
26th Oct 20207:00 amRNSPublication of a Prospectus
19th Oct 20204:43 pmRNSHalf-year Report
15th Oct 20204:45 pmRNSStatement re NAV and Interim Dividend
26th Aug 20205:19 pmRNSTransaction in Own Shares
29th Jul 20204:42 pmRNSTransaction in Own Shares
28th Jul 20204:48 pmRNSTransaction in Own Shares
22nd Jul 20203:12 pmRNSNet Asset Value(s)
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
22nd Jul 202012:18 pmRNSResult of AGM
29th May 202011:37 amRNSAnnual Financial Report
26th May 20204:54 pmRNSTransaction in Own Shares
27th Apr 20204:19 pmRNSTransaction in Own Shares
21st Apr 20205:17 pmRNSNet Asset Value & Final Dividend
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSSuspension of Dividend Investment Scheme
19th Mar 20201:48 pmRNSDirector Declaration
23rd Jan 20203:36 pmRNSNet Asset Value(s)
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20195:06 pmRNSTransaction in Own Shares
22nd Nov 20193:31 pmRNSDirector/PDMR Shareholding
22nd Nov 20192:45 pmRNSIssue of Equity
20th Nov 20194:44 pmRNSStatement re Dividend Investment Scheme
31st Oct 20194:42 pmRNSHalf-year Report
15th Oct 20192:33 pmRNSTransaction in Own Shares
15th Oct 20199:56 amRNSStatement re Net Asset Value and Interim Dividend
31st Jul 20193:37 pmRNSTransaction in Own Shares
4th Jul 20191:08 pmRNSNet Asset Value(s)
4th Jul 201912:55 pmRNSResult of AGM
24th May 20193:09 pmRNSAnnual Financial Report
20th May 20194:34 pmRNSTransaction in Own Shares
20th May 201911:29 amRNSTransaction in Own Shares
24th Apr 20199:47 amRNSIssue of Equity
5th Apr 20194:42 pmRNSHolding(s) in Company
8th Mar 20192:30 pmRNSDirector/PDMR Shareholding
8th Mar 20192:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.